Last reviewed · How we verify

NCT07071376

Lower Dialysate Temperature and Post-Dialysis Fatigue

Completed NA Last updated 16 April 2026
What this trial tests

NA trial testing cold dialysis in Dialysis Related Complication in 57 participants. Completed in 15 September 2025.

Timeline
15 May 2025
Primary endpoint
15 June 2025
15 September 2025

Quick facts

Lead sponsorBaskent University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment57
Start date15 May 2025
Primary completion15 June 2025
Estimated completion15 September 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Baskent University

Who can join

18 and older, any sex, with Dialysis Related Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The standard dialysate temperature is usually set at 36.5°C in hemodialysis applications. Since this temperature is close to the patient's body temperature, it is ideal for preventing the patient from experiencing hypothermia while ensuring cardiovascular stability. In the literature, it is seen that changing the dialysate temperature, especially cold dialysis applications, is used in the management of nausea, the effect on vital signs, determining hemodialysis adequacy and common complications, and in the management of symptoms such as hypotension, cardiac stability, vascular stability, fatigue, and muscle cramps. However, no study has been found using cold dialysis in the management of fatigue that develops after dialysis.Therefore, the aim of this study is to examine the effect of cold dialysis application on post-dialysis fatigue in patients receiving hemodialysis treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dialysis Related Complication

Currently open trials in the same condition.

Other Baskent University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07071376.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing